2027 "Beijing Inclusive Health Insurance" opens for enrollment; YIDU TECH (02158) serves as lead operator for the sixth consecutive year.

date
13:15 04/11/2026
avatar
GMT Eight
The 2027 "Beijing Inclusive Health Insurance" continues to uphold its mission of benefiting the public with "low threshold, broad coverage, and high protection." The premium remains unchanged at RMB195 per year, with cumulative coverage of RMB3.5 million. The product's coverage includes in-network out-of-pocket expenses, out-of-network inpatient self-paid expenses, and the costs of 165 high-cost specialty drugs from both domestic and overseas sources.
On November 4, the 2027 "Beijing Inclusive Health Insurance" officially opened for enrollment. This marks the sixth year that "Beijing Inclusive Health Insurance" has provided coverage and services to Beijing citizens, and also the sixth consecutive year that YIDU TECH (02158) has served as the lead operator. As an important component of Beijing's multi-tiered medical security system, "Beijing Inclusive Health Insurance" is jointly guided by the Beijing Municipal Medical Insurance Bureau and the Office of the Financial Committee of the CPC Beijing Municipal Committee, and strictly supervised by the Beijing Regulatory Bureau of the National Financial Regulatory Administration. Over the past six years, the product has consistently adhered to its inclusive positioning, closely aligned with basic medical insurance, and actively responded to the multi-tiered and diversified medical security needs of Beijing citizens. 2027 "Beijing Inclusive Health Insurance" officially launched Premium unchanged for 6 years, inclusive mission remains steadfast The 2027 "Beijing Inclusive Health Insurance" continues to uphold its public-benefit mission of "low threshold, broad coverage, and high protection," with the premium maintained at RMB195/year unchanged and cumulative coverage of RMB3.5 million. The product's coverage includes in-network out-of-pocket expenses, out-of-network inpatient self-pay expenses, and 165 high-cost specialty drugs both domestic and overseas. Among these, there are 53 domestic specialty drugs, 60 overseas specialty drugs, and the number of specialty drug 2 medications has increased to 52, with the addition of multiple cutting-edge drugs in areas such as oncology, high-cost chronic diseases, CAR-T innovative therapies, and rare diseases, with zero deductible, effectively alleviating the burden of high medical costs for patients with severe illnesses and their families. Since its launch, enrollment in "Beijing Inclusive Health Insurance" has steadily increased year by year, with cumulative enrollment exceeding 19.8 million person-times. The beneficiary population has also expanded year by year. As of now, cumulative claims paid have exceeded 740,000 person-times, with the highest single claim reaching RMB935,000. Claims cases cover all age groups, with the oldest claimant being a 105-year-old elderly person and the youngest being an infant less than one month old. Behind every claims figure lies a family's real needs and rekindled hope, embodying the product's sincere mission of "taking from the people and benefiting the people." Notably, enrollment is not limited by age, household registration, occupation, or health status. All Beijing basic medical insurance enrollees, new Beijing residents who hold Beijing household registration or a Beijing residence permit and have participated in basic medical insurance elsewhere, central government-funded medical care personnel, and specific groups managed by the Beijing Municipal Medical Insurance Bureau and other relevant government departments (including land requisition resettled persons, medical care recipients, retired personnel, and military retirees) are eligible to enroll and file claims. Health services iteratively upgraded, extending from "insuring against illness" to "promoting health" The 2027 product adds three new services: early cancer screening, early Alzheimer's disease screening, and an AI health steward, advancing coverage from "post-illness reimbursement" to "pre-illness prevention." Among these, the early cancer screening service targets key cancers including lung cancer, colorectal cancer, gastric cancer, breast cancer, liver cancer, and cervical cancer, assessing enrollees' disease risk and providing early warnings through various methods such as screening questionnaires, at-home self-testing, and specialized testing; the early Alzheimer's disease screening service is aimed at middle-aged and elderly enrollees, helping to identify cognitive decline risks early through professional cognitive function screening and at-home sample collection and testing, winning valuable time windows for early intervention; the AI health steward leverages artificial intelligence technology to provide enrollees with 724-hour intelligent consultation, physical examination report interpretation, chronic disease management, and other one-stop health consultation services, making professional health management readily accessible. In addition, all enrollees can enjoy general health services and pharmacy discount benefits. First, they can use health services free of charge 5 times per year, covering diverse scenarios such as medical accompaniment, home nursing, home rehabilitation, home testing, and daily living care, precisely matching the individualized needs of different enrollees. Second, they can enjoy a 10% discount on pharmacy purchases throughout the year, usable 12 times per year, with an annual total subsidy of RMB1,800 and a maximum single subsidy of RMB400, further reducing the burden of daily medication costs. AI-powered, focused on full-cycle health protection needs As an important part of building Beijing's multi-tiered medical security system, "Beijing Inclusive Health Insurance" has gone through six years, with continuous coverage upgrades and service optimization, becoming the "Beijing model" for inclusive insurance development in mega-cities. In this process, YIDU TECH leverages the AI capabilities of its "AI Medical Brain" YiduCore to provide "Beijing Inclusive Health Insurance" with a full-process one-stop solution covering product design, system construction, platform operation, marketing and promotion, intelligent customer service, and intelligent claims, using technological strength to help improve the quality and efficiency of inclusive insurance services. Insurance protection addresses not only the issue of "being able to afford medical care" but also the need to move health risk thresholds forward and respond to citizens' real needs for full-lifecycle health management. On the basis of continuously improving medical protection and existing health services, "Beijing Inclusive Health Insurance" has added services such as early cancer screening, early Alzheimer's disease screening, and an AI health steward, so that protection is reflected not only in "being able to get reimbursed" at critical moments but also throughout full-lifecycle health guardianship, promoting the leap from "having insurance for illness" to "having management for health," and further enhancing enrollees' sense of gain, happiness, and satisfaction. Behind this is YIDU TECH's long-term accumulation and scenario deployment capabilities in the medical AI field. As of now, YIDU TECH has deeply participated in "Inclusive Insurance" projects in 5 provinces and 13 cities including Beijing and Shenzhen, with cumulative service to over 45 million enrolled users. By deeply integrating AI capabilities with real-world medical application scenarios, YIDU TECH continues to explore collaborative innovation across physicians, patients, pharmaceuticals, insurance, and health, helping to build a more inclusive, equitable, and comprehensive medical and health protection system. Xu Jiming, co-founder and CEO of YIDU TECH, stated: "As an innovative technology enterprise deeply engaged in medical AI for the long term, YIDU TECH is committed to deeply integrating technological capabilities with real-world medical application scenarios and promoting deep collaboration across physicians, patients, pharmaceuticals, insurance, and health. In the future, we will continue to innovate in products and services, injecting AI momentum to help achieve the strategic goal of 'Healthy China 2030.'"